Aligned Genetics Inc Asset Resilience Ratio
Aligned Genetics Inc asset resilience ratio. Aligned Genetics Inc (238120) has an Asset Resilience Ratio of 2.22% as of September 2025. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing. See 238120 defensive interval ratio to measure how many days the company can operate on defensive assets alone.
Liquid Assets
Total Assets
Resilience Assessment
Asset Resilience Ratio of Aligned Genetics Inc (2015–2024)
Asset resilience ratio of Aligned Genetics Inc from 2015 to 2024. This chart shows how Aligned Genetics Inc's Asset Resilience Ratio has changed over time. Read how much debt does Aligned Genetics Inc carry for a breakdown of total debt and financial obligations.
Liquid Assets Composition Over Time
This chart breaks down Aligned Genetics Inc's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. For the complete balance sheet picture, see how large is Aligned Genetics Inc's balance sheet.
Current Liquid Assets Breakdown
| Component | Amount | % of Total Assets |
|---|---|---|
| Cash & Equivalents | ₩0.00 | 0% |
| Short-term Investments | ₩1000.00 Million | 2.22% |
| Total Liquid Assets | ₩1000.00 Million | 2.22% |
Asset Resilience Insights
- Limited Liquidity: Aligned Genetics Inc maintains only 2.22% of assets in liquid form.
- This low level may indicate efficient asset utilization but could pose risks during economic downturns.
- The company has significant short-term investments, indicating active treasury management.
Aligned Genetics Inc Industry Peers by Asset Resilience Ratio
Compare Aligned Genetics Inc's asset resilience ratio with other companies in the same industry.
| Company | Industry | Asset Resilience Ratio |
|---|---|---|
|
Shenzhen New Industries Biomedical
SHE:300832 |
Medical Devices | 9.95% |
|
Double Medical Technology Inc
SHE:002901 |
Medical Devices | 12.59% |
|
BMC Medical Co. Ltd. A
SHE:301367 |
Medical Devices | 44.96% |
|
Emvision Medical Devices Ltd
AU:EMV |
Medical Devices | 0.06% |
|
Hironic Co. Ltd
KQ:149980 |
Medical Devices | 17.42% |
|
DRGEM Corporation
KQ:263690 |
Medical Devices | 2.12% |
|
Oncosil Medical Ltd
AU:OSL |
Medical Devices | 0.00% |
|
Adherium Ltd
AU:ADR |
Medical Devices | 15.45% |
Aligned Genetics Inc Asset Resilience Ratio by Year (2015–2024)
Aligned Genetics Inc asset resilience ratio by year from 2015 to 2024. The table below shows the annual Asset Resilience Ratio data for Aligned Genetics Inc.
| Year | Asset Resilience Ratio (%) | Liquid Assets | Total Assets | Change |
|---|---|---|---|---|
| 2024-12-31 | 21.88% | ₩9.69 Billion ≈ $6.56 Million |
₩44.28 Billion ≈ $30.00 Million |
+18.97pp |
| 2023-12-31 | 2.90% | ₩1.19 Billion ≈ $804.80K |
₩40.93 Billion ≈ $27.74 Million |
-8.63pp |
| 2022-12-31 | 11.53% | ₩4.25 Billion ≈ $2.88 Million |
₩36.90 Billion ≈ $25.01 Million |
-11.27pp |
| 2021-12-31 | 22.80% | ₩7.86 Billion ≈ $5.33 Million |
₩34.47 Billion ≈ $23.36 Million |
-24.84pp |
| 2020-12-31 | 47.64% | ₩12.14 Billion ≈ $8.23 Million |
₩25.48 Billion ≈ $17.27 Million |
-8.82pp |
| 2019-12-31 | 56.46% | ₩13.90 Billion ≈ $9.42 Million |
₩24.62 Billion ≈ $16.68 Million |
+26.38pp |
| 2018-12-31 | 30.07% | ₩6.92 Billion ≈ $4.69 Million |
₩23.00 Billion ≈ $15.59 Million |
-50.19pp |
| 2017-12-31 | 80.26% | ₩19.51 Billion ≈ $13.22 Million |
₩24.31 Billion ≈ $16.47 Million |
-3.13pp |
| 2016-12-31 | 83.39% | ₩21.56 Billion ≈ $14.61 Million |
₩25.86 Billion ≈ $17.53 Million |
+79.15pp |
| 2015-12-31 | 4.23% | ₩290.44 Million ≈ $196.83K |
₩6.86 Billion ≈ $4.65 Million |
-- |
About Aligned Genetics Inc
Aligned Genetics, Inc. offers cellular imaging and biomolecular analysis solutions worldwide. It also provides molecular diagnostic solutions for rapid results under the Genescale name; and advanced imaging and analysis solutions under the Logos Biosystems name. The company was formerly known as Logos Biosystems, Inc. and changed its name to Aligned Genetics, Inc. in September 2020. Aligned Genet… Read more